Growth by design: building a global health partner from Japan's heart

NIPRO CORPORATION is expanding from its Osaka roots into a truly global, comprehensive healthcare company with a spirit of “WA-gokoro”—anchored in Japanese values, engineered for speed, and focused on patient outcomes.

- 

Dialyzer, often referred to as an "artificial kidney," with the world's No. 2 market share.

The first thing investors notice is NIPRO’s impressive scale.

The company counts about 40,000 employees worldwide, with roughly 30,000 based outside Japan and representation in 62 countries. Overseas revenue passed 51% last year, and leadership targets 60% within five years. “As long as you see the NIPRO brand and our colleagues, you see the same philosophy, everywhere,” said President Tsuyoshi Yamazaki.

From glass to global: a platform for durable growth

NIPRO’s story began in 1954 with glass. Its founder automated labor-intensive ampoule making, helping Japan meet surging vaccine demand and setting the tone for a company built on practical innovation. That engineering focus soon moved into medical devices—needles, syringes, IV sets and dialyzers—and then into today’s four pillars: medical devices, pharmaceuticals, pharma packaging, and regenerative medicines.